Prime-boost Vaccination Using Dna and Whole Inactivated Virus Vaccines Provides Limited Protection Against Virulent Feline Immunodeficiency Virus.
From: Retrovirus Research Laboratory, Institute of Comparative Medicine, Faculty of Veterinary Medicine, University of Glasgow, Bearsden Road, Glasgow G61 1QH, United Kingdom. s.dunham@vet.gla.ac.uk
Vaccine
- Publish Date: Nov 2006
- ISSN: 0264-410X
- Volume: 24
- Issue: 49-50
- Pages: 7095-108
- Medium: Print
- Language: English
- Citation (JAMA): Dunham Stephen P, Bruce Jennifer, Klein Dieter, et al. Prime-boost Vaccination Using Dna and Whole Inactivated Virus Vaccines Provides Limited Protection Against Virulent Feline Immunodeficiency Virus.. Vaccine Nov 2006;24:7095-108
Abstract
Protection against feline immunodeficiency virus (FIV) has been achieved using a variety of vaccines notably whole inactivated virus (WIV) and DNA. However protection against more virulent isolates, typical of those encountered in natural infections, has been difficult to achieve. In an attempt to improve protection against virulent FIV(GL8), we combined both DNA and WIV vaccines in a “prime-boost” approach. Thirty cats were divided into four groups receiving vaccinations and one unvaccinated control group. Following viral challenge, two vaccinated animals, one receiving DNA alone and one the prime-boost vaccine remained free of viraemia, whilst all controls became viraemic. Animals vaccinated with WIV showed apparent early enhancement of infection at 2 weeks post challenge (pc) with higher plasma viral RNA loads than control animals or cats immunised with DNA alone. Despite this, animals vaccinated with WIV or DNA alone showed significantly lower proviral loads in peripheral blood mononuclear cells and mesenteric lymph node cells, whilst those receiving the DNA-WIV prime-boost vaccine showed significantly lower proviral loads in PBMC, than control animals, at 35 weeks pc. Therefore both DNA and WIV vaccines conferred limited protection against viral challenge but the combination of WIV and DNA in a prime-boost approach appeared to offer no significant advantage over either vaccine alone.
Mesh Headings (Keywords): Animals, Antibodies, Viral, Cats, Enzyme-Linked Immunosorbent Assay, Feline Acquired Immunodeficiency Syndrome, Immunity, Cellular, Immunization Schedule, Immunization, Secondary, Immunodeficiency Virus, Feline, Integrases, Interferon Type II, Lymph Nodes, Lymphocyte Subsets, RNA, Viral, Spleen, Vaccines, DNA, Vaccines, Inactivated, Viral Load, Viral Vaccines, Viremia
Check for Full Text / PubMed Unique Identifier (PMID): 17049683
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.